|
Goodwill and Other Intangible Assets (Other Intangible Assets) (Details) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Goodwill | $ 15,545us-gaap_Goodwill | $ 0us-gaap_Goodwill |
| Amortization of Intangible Assets | 773us-gaap_AmortizationOfIntangibleAssets | 0us-gaap_AmortizationOfIntangibleAssets |
| Rent payable | 209us-gaap_DeferredRentCreditNoncurrent | 557us-gaap_DeferredRentCreditNoncurrent |
| Finite-lived intangible assets, gross | 47,468us-gaap_FiniteLivedIntangibleAssetsGross | |
| Finite-Lived Intangible Assets, Accumulated Amortization | 686us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization | |
| Finite-Lived Intangible Assets, Net | 46,782us-gaap_FiniteLivedIntangibleAssetsNet | |
| Diagnostic Test - Thyroid | ||
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Finite-lived intangible asset, useful life | 9 years | |
| Finite-lived intangible assets, gross |
8,519us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestThyroidMember |
|
| Finite-Lived Intangible Assets, Accumulated Amortization |
0us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestThyroidMember |
|
| Finite-Lived Intangible Assets, Net |
8,519us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestThyroidMember |
|
| Diagnostic Test - Pancreas | ||
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Finite-lived intangible asset, useful life | 7 years | |
| Finite-lived intangible assets, gross |
2,882us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestPancreasMember |
|
| Finite-Lived Intangible Assets, Accumulated Amortization |
154us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestPancreasMember |
|
| Finite-Lived Intangible Assets, Net |
2,728us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestPancreasMember |
|
| Biobank | ||
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Finite-lived intangible asset, useful life | 4 years | |
| Finite-lived intangible assets, gross |
1,575us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_BioBankMember |
|
| Finite-Lived Intangible Assets, Accumulated Amortization |
147us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_BioBankMember |
|
| Finite-Lived Intangible Assets, Net |
1,428us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_BioBankMember |
|
| Diagnostic Test - Pancreas RedPath [Member] [Member] | ||
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Finite-lived intangible asset, useful life | 7 years | |
| Finite-lived intangible assets, gross |
16,141us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestPancreasRedPathMemberMember |
|
| Finite-Lived Intangible Assets, Accumulated Amortization |
385us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestPancreasRedPathMemberMember |
|
| Finite-Lived Intangible Assets, Net |
15,756us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestPancreasRedPathMemberMember |
|
| Diagnostic Test - Barrett's RedPath | ||
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Finite-lived intangible asset, useful life | 9 years | |
| Finite-lived intangible assets, gross |
18,351us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestBarrettsRedPathMember |
|
| Finite-Lived Intangible Assets, Accumulated Amortization |
0us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestBarrettsRedPathMember |
|
| Finite-Lived Intangible Assets, Net |
18,351us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestBarrettsRedPathMember |
|
| CLIA Diagnostic Lab [Member] | ||
| Acquired Finite-Lived Intangible Assets [Line Items] | ||
| Finite-lived intangible asset, useful life | 2 years 3 months | |
| Finite-lived intangible assets, gross |
609us-gaap_FiniteLivedIntangibleAssetsGross / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_CLIADiagnosticLabMember |
|
| Finite-Lived Intangible Assets, Accumulated Amortization |
87us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_CLIADiagnosticLabMember |
|
| Finite-Lived Intangible Assets, Net |
$ 522us-gaap_FiniteLivedIntangibleAssetsNet / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_CLIADiagnosticLabMember |
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|